Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cancers|April 13, 2023
Emerging Targeted Therapies for HER2-Positive Breast CancerMaría Florencia Mercogliano, Sofía Bruni, Florencia Luciana Mauro, et al.
Frontiers in Oncology|May 12, 2020
Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast CancerMaría Florencia Mercogliano, Sofía Bruni, Patricia V Elizalde, et al.
Cancers|February 5, 2021
Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer ImmunotherapyMaría Florencia Mercogliano, Sofía Bruni, Florencia Mauro, et al.
Frontiers in Oncology|June 7, 2023
Cancer immune exclusion: breaking the barricade for a successful immunotherapySofia Bruni, María Florencia Mercogliano, Florencia Luciana Mauro, et al.
Breast Cancer Research : BCR|December 7, 2014
Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growthFranco Izzo, Florencia Mercogliano, Leandro Venturutti, et al.
Scientific Reports|April 27, 2026
Human Tamm-Horsfall protein as a novel antitumor therapy for triple negative breast cancer and other solid tumorsMaría Florencia Mercogliano, Sofia Bruni, Mara De Martino, et al.
Psychoneuroendocrinology|June 24, 2016
Juvenile exposure to a high fat diet promotes behavioral and limbic alterations in the absence of obesityAngeles Vinuesa, Carlos Pomilio, Martin Menafra, et al.
Immunology and Cell Biology|November 5, 2016
Inhibition of MHC-I by Brucella abortus is an early event during infection and involves EGFR pathwayLis N Velásquez, M Ayelén Milillo, M Victoria Delpino, et al.
Nature Reviews. Endocrinology|December 15, 2023
Pituitary stem cells: past, present and future perspectivesMaría Inés Pérez Millán, Leonard Y M Cheung, Florencia Mercogliano, et al.
Molecular Therapy. Oncology|June 17, 2026
Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinomaBárbara Bueloni, Mariel Fusco, Esteban Fiore, et al.
Pageof 2